Journal of International Oncology››2016,Vol. 43››Issue (1): 26-28.doi:10.3760/cma.j.issn.1673-422X.2016.01.007
Previous ArticlesNext Articles
Guan Xuwen, Huang Dingzhi
Received:
2015-10-22Online:
2016-01-08Published:
2015-12-03Contact:
Huang Dingzhi E-mail:dingzhih72@163.comSupported by:
Tianjin Municipal Natural Science Foundation (15JCYBJC28200)
Guan Xuwen, Huang Dingzhi. Roles of MTH1 gene in the occurrence and treatment of cancers[J]. Journal of International Oncology, 2016, 43(1): 26-28.
[1] Patel A, Burton DG, Halvorsen K, et al. MutT Homolog 1 (MTH1) maintains multiple KRASdriven promalignant pathways[J]. Oncogene, 2015, 34(20): 2586-2596. DOI:10.1038/onc.2014.195. [2] Speina E, Arczewska KD, Gackowski D, et al. Contribution of hMTH1 to the maintenance of 8oxoguanine levels in lung DNA of nonsmallcell lung cancer patients[J]. J Natl Cancer Inst, 2005, 97(5): 384-395. [3] Borrego S, Vazquez A, Dasí F, et al. Oxidative stress and DNA damage in human gastric carcinoma: 8Oxo7′8dihydro2′deoxyguanosine (8oxodG) as a possible tumor marker[J]. Int J Mol Sci, 2013, 14(2): 3467-3486. DOI:10.3390/ijms14023467. [4] Gad H, Koolmeister T, Jemth AS, et al. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool[J]. Nature, 2014, 508(7495): 215-221. DOI:10.1038/nature13181. [5] Kim HS, Jung G. Notch1 increases snail expression under high reactive oxygen species conditions in hepatocellular carcinoma cells[J]. Free Radic Res, 2014, 48(7): 806-813. DOI:10.3109/10715762.2014.909595. [6] Qu Y, Dang S, Hou P. Gene methylation in gastric cancer [J]. Clin Chim Acta[J], 2013, 424: 53-65. DOI: 10.1016/j.cca.2013.05.002. [7] Weinberg F, Hamanaka R, Wheaton WW, et al. Mitochondrial metabolism and ROS generation are essential for Krasmediated tumorigenicity[J]. Proc Natl Acad Sci USA, 2010, 107(19): 8788-8793. DOI:10.1073/pnas.1003428107. [8] Song WJ, Jiang P, Cai JP, et al. Expression of cytoplasmic 8oxoGsn and MTH1 correlates with pathological grading in human gastric cancer[J]. Asian Pac J Cancer Prev, 2015, 16(15): 6335-6338. DOI:10.7314/APJCP.2015.16.15.6335. [9] Tsuzuki T, Egashira A, Igarashi H, et al. Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8oxodGTPase[J]. Proc Natl Acad Sci USA, 2001, 98(20): 11456-11461. [10] Ohno M, Sakumi K, Fukumura R, et al. 8oxoguanine causes spontaneous de novo germline mutations in mice[J]. Sci Rep, 2014, 4: 4689. DOI:10.1038/srep04689. [11] Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis[J]. Science, 2011, 331(6024): 15591564. DOI:10.1126/science.1203543. [12] Qi L, Sun B, Liu Z, et al. Wnt3a expression is associated with epithelialmesenchymal transition and promotes colon cancer progression[J]. J Exp Clin Cancer Res, 2014, 33: 107. DOI:10.1186/s13046-014-0107-4. [13] Rai P. Human Mut T Homolog 1 (MTH1): a roadblock for the tumorsuppressive effects of oncogenic RASinduced ROS[J]. Small GTPases, 2012, 3(2): 120-125. DOI:10.4161/sgtp.19556. [14] Rai P, Young JJ, Burton DG, et al. Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RASinduced DNA damage and premature senescence[J]. Oncogene, 2010, 30(12): 14891496. DOI:10.1038/onc.2010.520. [15] Yan X, Chen X, Liang H, et al. miR143 and miR145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer [J]. Mol Cancer, 2014, 13: 220. DOI: 10.1186/1476-4598-13-220. [16] Cho WC, Chow AS, Au JS. MiR145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1[J]. RNA Biol, 2011, 8(1): 125-131. [17] Huber KV, Salah E, Radic B, et al. Stereospecific targeting of MTH1 by (S)crizotinib as an anticancer strategy[J]. Nature, 2014, 508(7495): 222-227. DOI:10.1038/nature13194. [18] Streib M, Krling K, Richter K, et al. An organometallic inhibitor for the human repair enzyme 7,8dihydro8oxoguanosine triphosphatase[J]. Angew Chem Int Ed Engl, 2014, 53(1): 305309. DOI:10.1002/anie.201307849. [19] Smits VA, Gillespie DA. Cancer therapy. Targeting the poison within[J]. Cell Cycle, 2014, 13(15): 2330-2333. [20] Gao W, Cao W, Sun Y, et al. AuNP flarescapped mesoporous silica nanoplatform for MTH1 detection and inhibition[J]. Biomaterials, 2015, 69: 212-221. DOI:10.1016/j.biomaterials.2015.08.021. [21] Zhu Y, Zhang L, Zhang GD, et al. Potential mechanisms of benzyl isothiocyanate suppression of invasion and angiogenesis by the U87MG human glioma cell line[J]. Asian Pac J Cancer Prev, 2014, 15(19): 8225-8228. [22] Helleday T. Cancer phenotypic lethality, exemplified by the nonessential MTH1 enzyme being required for cancer survival[J]. Ann Oncol, 2014, 25(7): 1253-1255. DOI:10.1093/annonc/mdu158. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||